Leptomeningeal Metastases Clinical Trial
Official title:
Phase IB Study of Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
This study is to find a safe dose of the combination of Avelumab and Whole Brain Radiotherapy (WBRT) in patients with Leptomeningeal Disease.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01438021 -
Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease
|
N/A | |
Completed |
NCT02616393 -
Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases
|
Phase 2 | |
Completed |
NCT03101579 -
Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer
|
Phase 1 | |
Not yet recruiting |
NCT06462092 -
Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT00005812 -
Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
|
Phase 2 | |
Terminated |
NCT03661424 -
BATs in Patients With Breast Cancer and Leptomeningeal Metastases
|
Phase 1 | |
Active, not recruiting |
NCT05289908 -
Intrathecal Pemetrexed for Leptomeningeal Metastasis
|
Phase 1/Phase 2 | |
Recruiting |
NCT05184816 -
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
|
Phase 1 | |
Not yet recruiting |
NCT03613181 -
ANG1005 in Leptomeningeal Disease From Breast Cancer
|
Phase 3 | |
Terminated |
NCT03275402 -
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
|
Phase 2/Phase 3 | |
Completed |
NCT01645839 -
Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer
|
Phase 3 | |
Completed |
NCT03520504 -
Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases
|
Phase 1 | |
Completed |
NCT00992602 -
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
|
Phase 2 | |
Completed |
NCT00005811 -
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment
|
Phase 2 | |
Active, not recruiting |
NCT04343573 -
Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors
|
Phase 2 |